3SBio Inc (83B) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.037x

Based on the latest financial reports, 3SBio Inc (83B) has a cash flow conversion efficiency ratio of 0.037x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€592.24 Million ≈ $692.39 Million USD) by net assets (€15.96 Billion ≈ $18.66 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 83B company net worth for the company's overall valuation and market capitalisation.

3SBio Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how 3SBio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

3SBio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of 3SBio Inc ranked by their cash flow conversion efficiency. Explore how high is 3SBio Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiangsu Boqian New Materials Stock Co Ltd SHG:605376	0.031x
Protagonist Therapeutics Inc NASDAQ:PTGX	-0.003x
Rigetti Computing Inc NASDAQ:RGTI	-0.029x
Frontdoor Inc NASDAQ:FTDR	0.444x
United Plantations Bhd KLSE:2089	0.337x
Dropbox Inc NASDAQ:DBX	-0.131x
Scout24 AG XETRA:G24	0.247x
AAK AB ST:AAK	0.014x

Annual Cash Flow Conversion Efficiency for 3SBio Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of 3SBio Inc from 2016 to 2025. View 3SBio Inc stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€30.44 Billion ≈ $35.58 Billion	€9.67 Billion ≈ $11.30 Billion	0.318x	+78.98%
2024-12-31	€18.04 Billion ≈ $21.09 Billion	€3.20 Billion ≈ $3.74 Billion	0.177x	+40.72%
2023-12-31	€16.51 Billion ≈ $19.31 Billion	€2.08 Billion ≈ $2.44 Billion	0.126x	-10.91%
2022-12-31	€15.40 Billion ≈ $18.00 Billion	€2.18 Billion ≈ $2.55 Billion	0.142x	+31.48%
2021-12-31	€14.66 Billion ≈ $17.14 Billion	€1.58 Billion ≈ $1.85 Billion	0.108x	+4.86%
2020-12-31	€13.09 Billion ≈ $15.31 Billion	€1.34 Billion ≈ $1.57 Billion	0.103x	-43.64%
2019-12-31	€10.36 Billion ≈ $12.11 Billion	€1.89 Billion ≈ $2.21 Billion	0.182x	+41.09%
2018-12-31	€8.91 Billion ≈ $10.41 Billion	€1.15 Billion ≈ $1.34 Billion	0.129x	-8.27%
2017-12-31	€7.63 Billion ≈ $8.92 Billion	€1.07 Billion ≈ $1.26 Billion	0.141x	-5.15%
2016-12-31	€6.77 Billion ≈ $7.91 Billion	€1.00 Billion ≈ $1.17 Billion	0.148x	--

About 3SBio Inc

F:83B Germany Biotechnology

Market Cap

$5.09 Billion

€4.35 Billion EUR

Market Cap Rank

#3514 Global

#652 in Germany

Share Price

€1.74

Change (1 day)

-1.39%

52-Week Range

€1.63 - €3.68

All Time High

€3.88